Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for ECL and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ECL and 80,000+ other tickers.
See exactly how ECL's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ECL and 80,000+ other tickers.
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty…
Ecolab (ECL) reported earnings 30 days ago. What's next for the stock?
ST. PAUL, Minn.--(BUSINESS WIRE)--Ecolab Inc. will host its 2026 Investor Day in conjunction with the SC26 Supercomputing Conference on Tuesday, November 17, 2026, in Chicago. Christophe Beck, chairman, president and chief executive officer; Scott Kirkland, chief financial officer; and other members of Ecolab's senior leadership team will provide an in-depth look at the technology, innovation and growth strategies that are strengthening the company's business model, market position and long-ter.
Bank of New York Mellon Corp acquired a new position in shares of Ecolab Inc. (NYSE: ECL) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 1,483,725 shares of the basic materials company's stock, valued at approximately $413,381,000. Bank of New York Mellon Corp
ECL's $4.75B CoolIT deal expands its AI data-center cooling opportunity, but higher debt and financing costs raise execution risks.
ECL's accelerating High-Tech, Digital and Life Sciences growth supports its outlook, but rising debt and financing costs keep the buy case cautious.